Scientific letters

• Differences between cycle ergometer and treadmill in cardiopulmonary exercise testing in patients with Fontan circulation

  Raquel Ladrón-Abia, Begoña Manso García, Pilar Cejudo Ramos, Mirella Gaboli, María José Rodríguez Puras, Pastora Gallego

  Rev Esp Cardiol. 2023;76:821-3

• Early hospital discharge after cardiac electrophysiology procedures without outpatient clinic support

  Luis Álvarez-Acosta, Carlos Bande-Sánchez-Girón, Diego Valdivia-Miranda, Nerea Torres González, Pablo Ruiz-Hernández, Julio Hernández-Afonso

  Rev Esp Cardiol. 2023;76:823-6

• Time trend, willingness and knowledge of law enforcement agencies officers to act as first responders in out-of-hospital cardiac arrests

  Irene Pérez-Regueiro, Lucía Carcedo-Argüelles, Paula Menéndez-Angulo, Rocío Guinea-Rivera, Alberto Lana

  Rev Esp Cardiol. 2023;76:826-8

• STEMI code cancelation after telematic assessment: patient characteristics and prognosis

  Carmen Martín Domínguez, Jaime Aboal Viñas, Pablo Loma-Osorio Rincón, Blanca Herrera Martínez, Víctor Agudelo Montañez, Ramón Brugada Terradellas

  Rev Esp Cardiol. 2023;76:828-31

• 30-day readmissions for circulatory system diseases in patients over 75 years with heart failure in Spain (2016-2018)

  Alberto Esteban-Fernández, Manuel Anguita-Sánchez, María Anguita-Gámez, Nicolás Rosillo, Náyade del Prado, José Luis Bernal

  Rev Esp Cardiol. 2023;76:655-6

• Recurrence of acute coronary syndrome in patients with elevated levels of triglyceride-rich lipoproteins

  Néstor Báez-Ferrer, Manuel Alejandro Rivero-García, Jorge Joaquín Castro-Martín, Pablo Avanzas, Pedro Abreu-González, Alberto Domínguez-Rodríguez

  Rev Esp Cardiol. 2023;76:657-8

• Ultrasound versus fluoroscopy-guided axillary vein access for cardiac device implantation

  Sok-Sithikun Bun, Philippe Taghji, Fabien Squara, Pierre-Laurent Massoure, Jean-Claude Deharo, Emile Ferrari

  Rev Esp Cardiol. 2023;76:659-60

• Feasibility and safety of early discharge after transcatheter aortic valve implantation

  Jorge García-Carreño, Eduardo Zatarain, María Tamargo, Jaime Elízaga, Javier Bermejo, Francisco Fernández-Avilés

  Rev Esp Cardiol. 2023;76:660-3

• Hereditary transthyretin amyloidosis caused by p.Ser43Asn variant. A new endemic variant in Ecuador

  Elena Porres-López, Fernando de Frutos, Lorenzo Silva-Hernández, Lucía Galán, Esther González-López, Pablo García-Pavía

  Rev Esp Cardiol. 2023;76:564-6

• Fluid-dynamic impact of commissural alignment in transcatheter aortic valve implantation

  Ignacio J. Amat-Santos, José Sierra-Pallares, Alfredo Redondo, Sara Blasco-Turrión, Juan Pablo Sánchez-Luna, José Carlos González-Gutiérrez

  Rev Esp Cardiol. 2023;76:566-8

• Potential for controlled heart donation after circulatory determination of death

  Nerea Martínez-Franco, Eva Oliver-Juan, Jaume Tort, Laura Anguela-Calvet, Nicolás Manito-Lorite, Gabriel Moreno-González

  Rev Esp Cardiol. 2023;76:568-71

• Outflow tract ventricular tachycardia ablation from the axillary artery

  Cristina Lozano-Granero, Eduardo Franco, Roberto Matía-Francés, Antonio Hernández-Madrid, José Luis Zamorano, Javier Moreno

  Rev Esp Cardiol. 2023;76:571-3

• Clinical outcomes in heart transplant recipients with coronary abnormalities in the donor graft

  Pablo Fernández de-Aspe, Eduardo Barge-Caballero, Guillermo Aldama-López, Laura Fernández-Arias, José Manuel Vázquez-Rodríguez, María G. Crespo-Leiro

  Rev Esp Cardiol. 2023;76:473-4

• Transcatheter aortic valve implantation with the self-expandable and precrimped Vienna valve: first-in-man experience

  José Carlos González-Gutiérrez, Sara Blasco-Turrión, Alberto Campo-Prieto, Juan Pablo Sánchez-Luna, J. Alberto San Román, Ignacio J. Amat-Santos

  Rev Esp Cardiol. 2023;76:475-7

• CANDI study: chlorthalidone vs acetazolamide in patients with diuretic resistance in acute heart failure

  Paula Vela Martín, Andrea Matutano Muñoz, David Sánchez Ortiz, Fernando Domínguez, Ana Royuela, Marta Cobo Marcos

  Rev Esp Cardiol. 2023;76:477-80

• Treatment of mild asymptomatic cardiotoxicity in early-stage HER 2-positive breast cancer. Is it justified?

  Gerard Oristrell, Gemma Burcet, Filipa Valente, Santiago Escrivá-De-Romaní, Miriam Arumí, Ignacio Ferreira-González

  Rev Esp Cardiol. 2023;76:480-3

• Quality control of cardiovascular risk in hospitalized diabetic patients in cardiology services

  Javier Cuevas, Daniel Morena, Luis Gutiérrez, Pablo Flórez, Valentina Chiminazzo, Jesús María de la Hera

  Rev Esp Cardiol. 2023;76:483-5

• Initial experience with the coronary sinus reducer for the treatment of refractory angina in Spain

  Oriol Rodríguez-Leor, Santiago Jiménez Valero, Josep Gómez-Lara, Javier Escaned, Pablo Avanzas, Saleta Fernández, en representación de los investigadores del registro Re2-Cor

  Rev Esp Cardiol. 2023;76:381-3

• Early remote monitoring of pacemaker devices and benefits of this paradigm shift. The FAST REMOTE study

  Irene Valverde André, Mar González Vasserot, Beatriz Gonzalez Chana, Carlos González Matos, Lola Villagraz Tecedor, F. Javier García Fernández, en representación de los investigadores del estudio FAST REMOTE

  Rev Esp Cardiol. 2023;76:379-81

• Impact of the revised hemodynamic definition of pulmonary hypertension

  José Luis Callejas Rubio, Eduardo Moreno Escobar, Emilia Navascues Martínez, Pilar Martín de la Fuente, Teresa Gil Jiménez, Norberto Ortego Centeno

  Rev Esp Cardiol. 2023;76:383-4